T-cell therapies for T-cell lymphoma
- 1 September 2019
- journal article
- review article
- Published by Elsevier in Cytotherapy
- Vol. 21 (9) , 935-942
Abstract
No abstract availableKeywords
Funding Information
- Lymphoma Research Foundation
This publication has 59 references indexed in Scilit:
- Novel Immunotherapies for T Cell Lymphoma and LeukemiaCurrent Hematologic Malignancy Reports, 2018
- Erratum to: Romidepsin for the treatment of relapsed/refractory peripheral T cell lymphoma: prolonged stable disease provides clinical benefits for patients in the pivotal trialJournal of Hematology & Oncology, 2017
- The aggressive peripheral T‐cell lymphomas: 2017American Journal of Hematology, 2017
- Novel Agents in the Treatment of Relapsed or Refractory Peripheral T-Cell LymphomaHematology/Oncology Clinics of North America, 2017
- Lymphoma classification update: T-cell lymphomas, Hodgkin lymphomas, and histiocytic/dendritic cell neoplasmsExpert Review of Hematology, 2017
- T-Cell Lymphoma: Recent Advances in Characterization and New Opportunities for TreatmentJNCI: Journal of the National Cancer Institute, 2016
- Changing the Paradigms of Treatment in Peripheral T-cell Lymphoma: From Biology to Clinical PracticeClinical Cancer Research, 2014
- Therapeutic options in relapsed or refractory peripheral T-cell lymphomaCancer Treatment Reviews, 2014
- Lymphoma classification and the tools of our trade: an introduction to the 2012 USCAP Long CourseLaboratory Investigation, 2013
- Evolving therapy of peripheral T-cell lymphoma: 2010 and beyondTherapeutic Advances in Hematology, 2011